Advertisement

Clostridium difficile (Clostridioides difficile) Infection Surveillance in Long-Term Care Facilities

  • Amar KrishnaEmail author
  • Justin Oring
Chapter

Abstract

Surveillance of Clostridium (Clostridioides) difficile infection (CDI) in long-term care facilities (LTCFs) will help determine CDI burden in LTCFs, evaluate infection trends, and detect outbreaks. Surveillance will also help determine the efficacy of infection control and antibiotic stewardship programs implemented to prevent the occurrence of CDI. This chapter describes the various methods used for CDI surveillance in LTCFs and the strengths and drawbacks of each of these methods.

Keywords

Clostridium (Clostridioides) difficile Surveillance Laboratory-identified event Long-term care facility 

References

  1. 1.
    Smith PW, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008;29(9):785–814.CrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. Laboratory-identified multidrug-resistant organism (MDRO) & Clostridium difficile infection (CDI) events for long-term care facilities (LTCFs).Google Scholar
  3. 3.
    McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48.CrossRefGoogle Scholar
  4. 4.
    Palms DL, et al. The National Healthcare Safety Network Long-term Care Facility Component early reporting experience: January 2013–December 2015. Am J Infect Control. 2018;46(6):637–42.CrossRefGoogle Scholar
  5. 5.
    Stone ND. Post-Acute and Long Term Care: the changing national landscape. Presented at SHEA Spring Conference 2018.Google Scholar
  6. 6.
    Laffan AM, et al. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc. 2006;54(7):1068–73.CrossRefGoogle Scholar
  7. 7.
    Gaynes R, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis. 2004;38(5):640–5.CrossRefGoogle Scholar
  8. 8.
    Gase KA, et al. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network’s laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol. 2013;34(3):284–90.CrossRefGoogle Scholar
  9. 9.
    Kelly SG, et al. Inappropriate Clostridium difficile testing and consequent overtreatment and inaccurate publicly reported metrics. Infect Control Hosp Epidemiol. 2016;37(12):1395–400.CrossRefGoogle Scholar
  10. 10.
    Han A, Jump RL. Discrepancies between surveillance definition and the clinical incidence of Clostridium difficile infection in a Veterans Affairs long-term care facility. Infect Control Hosp Epidemiol. 2014;35(11):1435–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Detroit Medical Center/Wayne State UniversityDetroitUSA

Personalised recommendations